232 related articles for article (PubMed ID: 22931861)
1. Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules.
Boi F; Minerba L; Lai ML; Marziani B; Figus B; Spanu F; Borghero A; Mariotti S
J Endocrinol Invest; 2013 May; 36(5):313-20. PubMed ID: 22931861
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies.
Boi F; Lai ML; Marziani B; Minerba L; Faa G; Mariotti S
Eur J Endocrinol; 2005 Nov; 153(5):637-42. PubMed ID: 16260421
[TBL] [Abstract][Full Text] [Related]
3. Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules.
Kim ES; Lim DJ; Baek KH; Lee JM; Kim MK; Kwon HS; Song KH; Kang MI; Cha BY; Lee KW; Son HY
Thyroid; 2010 Aug; 20(8):885-91. PubMed ID: 20465529
[TBL] [Abstract][Full Text] [Related]
4. Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine-needle aspiration cytology.
Grani G; Calvanese A; Carbotta G; D'Alessandri M; Nesca A; Bianchini M; Del Sordo M; Vitale M; Fumarola A
Head Neck; 2015 Feb; 37(2):260-4. PubMed ID: 24375752
[TBL] [Abstract][Full Text] [Related]
5. Association of positive thyroid auto antibodies with thyroid carcinoma.
Ahmed T; Ali AA; Ahmed SU; Jahan M
Mymensingh Med J; 2012 Oct; 21(4):654-61. PubMed ID: 23134913
[TBL] [Abstract][Full Text] [Related]
6. Anti-Thyroid Antibodies and TSH as Potential Markers of Thyroid Carcinoma and Aggressive Behavior in Patients with Indeterminate Fine-Needle Aspiration Cytology.
Adhami M; Michail P; Rao A; Bhatt CR; Grodski S; Serpell JW; Lee JC
World J Surg; 2020 Feb; 44(2):363-370. PubMed ID: 31502005
[TBL] [Abstract][Full Text] [Related]
7. Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system.
Baser H; Topaloglu O; Tam AA; Evranos B; Alkan A; Sungu N; Dumlu EG; Ersoy R; Cakir B
Endocrine; 2016 Aug; 53(2):520-9. PubMed ID: 26972701
[TBL] [Abstract][Full Text] [Related]
8. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.
Wu X; Lun Y; Jiang H; Gang Q; Xin S; Duan Z; Zhang J
Endocrine; 2014 Aug; 46(3):554-60. PubMed ID: 24338678
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of papillary thyroid carcinoma in nodular Hashimoto's thyroiditis at the first diagnosis and during the follow-up.
Boi F; Pani F; Calò PG; Lai ML; Mariotti S
J Endocrinol Invest; 2018 Apr; 41(4):395-402. PubMed ID: 28875268
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies.
Boi F; Pani F; Mariotti S
Eur Thyroid J; 2017 Jul; 6(4):178-186. PubMed ID: 28868258
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy.
Rago T; Di Coscio G; Ugolini C; Scutari M; Basolo F; Latrofa F; Romani R; Berti P; Grasso L; Braverman LE; Pinchera A; Vitti P
Clin Endocrinol (Oxf); 2007 Sep; 67(3):363-9. PubMed ID: 17555501
[TBL] [Abstract][Full Text] [Related]
13. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
14. Association of Hashimoto's thyroiditis with thyroid cancer.
Azizi G; Keller JM; Lewis M; Piper K; Puett D; Rivenbark KM; Malchoff CD
Endocr Relat Cancer; 2014; 21(6):845-52. PubMed ID: 25217233
[TBL] [Abstract][Full Text] [Related]
15. The relationship between circulating estradiol and thyroid autoimmunity in males.
Chailurkit LO; Aekplakorn W; Ongphiphadhanakul B
Eur J Endocrinol; 2014 Jan; 170(1):63-7. PubMed ID: 24128431
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic Low Ovarian Reserve Is Associated with More Frequent Positive Thyroid Peroxidase Antibodies.
Chen CW; Huang YL; Tzeng CR; Huang RL; Chen CH
Thyroid; 2017 Sep; 27(9):1194-1200. PubMed ID: 28810821
[TBL] [Abstract][Full Text] [Related]
17. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
McLeod DS; Cooper DS; Ladenson PW; Ain KB; Brierley JD; Fein HG; Haugen BR; Jonklaas J; Magner J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
Thyroid; 2014 Jan; 24(1):35-42. PubMed ID: 23731273
[TBL] [Abstract][Full Text] [Related]
19. Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule.
Moon SS; Lee YS; Lee IK; Kim JG
Head Neck; 2012 Jul; 34(7):949-52. PubMed ID: 22127951
[TBL] [Abstract][Full Text] [Related]
20. Impact of Hashimoto's thyroiditis, TSH levels, and anti-thyroid antibody positivity on differentiated thyroid carcinoma incidence.
Gabalec F; Srbova L; Nova M; Hovorkova E; Hornychova H; Jakubikova I; Ryska A; Cap J
Endokrynol Pol; 2016; 67(1):48-53. PubMed ID: 26884115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
